Policy Topics

Health/biotechnology/medicine policy

Health/biotechnology/medicine policy

Showing 1 - 7 of 7 results
News

STPP Students Win 2nd Place in Policy Writing Competition

Oct 26, 2022
STPP students Natasha Dacic, Christina Del Greco, Natalia Harris, Kelsey Kochan, and Elena Levi-D’Ancona recently penned a policy brief about abortion rights in the United States for the National Science Policy Network's 2022 policy writing...
STPP Lecture Series, Harry A. and Margaret D. Towsley Foundation Lecture Series

Fatima Hassan on global vaccine equity and health justice

Dec 6, 2021, 11:00 am-12:00 pm EST
Join us for a talk on global vaccine equity and health justice with Fatima Hassan, human rights lawyer, social justice activist, and the founder of the Health Justice Initiative in South Africa; and Dr. Abdul El-Sayed, Towsley Policymaker in Residence at the Gerald R. Ford School of Public Policy.
Policy Brief

Ensuring global access to COVID-19 vaccines

January 21, 2021
|
Shobita Parthasarathy
Hopeful predictions estimate that by the end of 2021, only 10% of the world’s population will have received COVID-19 vaccines. Pfizer, Moderna, and other vaccine manufacturers can only produce so many doses at a time. Most of the first recipients...
Technology Assessment Project

Vaccine Hesitancy

September 2020 - May 2021
|
Zixuan Wang, Margarita Maria Rodriguez Morales, Kseniya Husak, Molly Kleinman, Shobita Parthasarathy
In winter 2020, a novel coronavirus (SARSCoV-2) that caused COVID-19 started its spread across the globe, and by July 2020, over 500,000 people worldwide had died of the disease. By March 2021, there were over 120 million cases and over 2.8 million deaths. To combat the pandemic and return to “normalcy”, experts estimate that at least 80% of the world’s population needs to be resistant to the virus, and most of the world’s population will require vaccination. This will be a challenge. In addition to facilitating widespread distribution, governments will need to combat “vaccine hesitancy”: an...